A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease. | ...

Compounded semaglutide has emerged as a significant development in the management of obesity and type 2 diabetes. As a ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

Video game addiction, a growing concern for parents and healthcare professionals alike, is increasingly recognized as a ...

Timing is everything, right? Diabetes educators explain when they eat their first meal to manage their blood sugars.

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

Researchers discovered the crystal structure of an alternative DNA configuration within the insulin gene, providing insights ...

Type 2 diabetes is characterized by the body's inability to use insulin effectively. Insulin is a hormone that helps regulate metabolism properly. The condition is the most common type of ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.